These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27340358)

  • 1. Intestinal-borne dermatoses significantly improved by oral application of Escherichia coli Nissle 1917.
    Manzhalii E; Hornuss D; Stremmel W
    World J Gastroenterol; 2016 Jun; 22(23):5415-21. PubMed ID: 27340358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The host response to the probiotic Escherichia coli strain Nissle 1917: specific up-regulation of the proinflammatory chemokine MCP-1.
    Ukena SN; Westendorf AM; Hansen W; Rohde M; Geffers R; Coldewey S; Suerbaum S; Buer J; Gunzer F
    BMC Med Genet; 2005 Dec; 6():43. PubMed ID: 16351713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of probiotic Escherichia coli strain Nissle 1917 depends on intestinal microbiota and adaptive immunity of the host.
    Gronbach K; Eberle U; Müller M; Olschläger TA; Dobrindt U; Leithäuser F; Niess JH; Döring G; Reimann J; Autenrieth IB; Frick JS
    Infect Immun; 2010 Jul; 78(7):3036-46. PubMed ID: 20421387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotic Properties of Escherichia coli Nissle in Human Intestinal Organoids.
    Pradhan S; Weiss AA
    mBio; 2020 Jul; 11(4):. PubMed ID: 32636253
    [No Abstract]   [Full Text] [Related]  

  • 5. Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling.
    Sturm A; Rilling K; Baumgart DC; Gargas K; Abou-Ghazalé T; Raupach B; Eckert J; Schumann RR; Enders C; Sonnenborn U; Wiedenmann B; Dignass AU
    Infect Immun; 2005 Mar; 73(3):1452-65. PubMed ID: 15731043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Simple
    Mokszycki ME; Leatham-Jensen M; Steffensen JL; Zhang Y; Krogfelt KA; Caldwell ME; Conway T; Cohen PS
    Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30291119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific proliferative and antibody responses of premature infants to intestinal colonization with nonpathogenic probiotic E. coli strain Nissle 1917.
    Cukrowska B; LodInová-ZádnIková R; Enders C; Sonnenborn U; Schulze J; Tlaskalová-Hogenová H
    Scand J Immunol; 2002 Feb; 55(2):204-9. PubMed ID: 11896937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial.
    Petersen AM; Mirsepasi H; Halkjær SI; Mortensen EM; Nordgaard-Lassen I; Krogfelt KA
    J Crohns Colitis; 2014 Nov; 8(11):1498-505. PubMed ID: 24972748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium.
    Wehkamp J; Harder J; Wehkamp K; Wehkamp-von Meissner B; Schlee M; Enders C; Sonnenborn U; Nuding S; Bengmark S; Fellermann K; Schröder JM; Stange EF
    Infect Immun; 2004 Oct; 72(10):5750-8. PubMed ID: 15385474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a specific
    Manzhalii E; Moyseyenko V; Kondratiuk V; Molochek N; Falalyeyeva T; Kobyliak N
    World J Hepatol; 2022 Mar; 14(3):634-646. PubMed ID: 35582294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh.
    Sarker SA; Sultana S; Reuteler G; Moine D; Descombes P; Charton F; Bourdin G; McCallin S; Ngom-Bru C; Neville T; Akter M; Huq S; Qadri F; Talukdar K; Kassam M; Delley M; Loiseau C; Deng Y; El Aidy S; Berger B; Brüssow H
    EBioMedicine; 2016 Feb; 4():124-37. PubMed ID: 26981577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of probiotics on gut flora, level of endotoxin and Child-Pugh score in cirrhotic patients: results of a double-blind randomized study.
    Lata J; Novotný I; Príbramská V; Juránková J; Fric P; Kroupa R; Stibůrek O
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1111-3. PubMed ID: 17998837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotics-containing yogurts suppress Helicobacter pylori load and modify immune response and intestinal microbiota in the Helicobacter pylori-infected children.
    Yang YJ; Sheu BS
    Helicobacter; 2012 Aug; 17(4):297-304. PubMed ID: 22759330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonpathogenic Escherichia coli strain Nissle 1917 inhibits signal transduction in intestinal epithelial cells.
    Kamada N; Maeda K; Inoue N; Hisamatsu T; Okamoto S; Hong KS; Yamada T; Watanabe N; Tsuchimoto K; Ogata H; Hibi T
    Infect Immun; 2008 Jan; 76(1):214-20. PubMed ID: 17967864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways.
    Grabig A; Paclik D; Guzy C; Dankof A; Baumgart DC; Erckenbrecht J; Raupach B; Sonnenborn U; Eckert J; Schumann RR; Wiedenmann B; Dignass AU; Sturm A
    Infect Immun; 2006 Jul; 74(7):4075-82. PubMed ID: 16790781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88.
    Remer KA; Bartrow M; Roeger B; Moll H; Sonnenborn U; Oelschlaeger TA
    Int J Med Microbiol; 2009 Nov; 299(7):467-78. PubMed ID: 19467927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral administration of Escherichia coli Nissle 1917 prevents allergen-induced dermatitis in mice.
    Weise C; Zhu Y; Ernst D; Kühl AA; Worm M
    Exp Dermatol; 2011 Oct; 20(10):805-9. PubMed ID: 21740462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and distribution of probiotic Escherichia coli Nissle 1917 clones in swine herds in Germany.
    Kleta S; Steinrück H; Breves G; Duncker S; Laturnus C; Wieler LH; Schierack P
    J Appl Microbiol; 2006 Dec; 101(6):1357-66. PubMed ID: 17105567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The commensal Escherichia coli CEC15 reinforces intestinal defences in gnotobiotic mice and is protective in a chronic colitis mouse model.
    Escribano-Vazquez U; Verstraeten S; Martin R; Chain F; Langella P; Thomas M; Cherbuy C
    Sci Rep; 2019 Aug; 9(1):11431. PubMed ID: 31391483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-8, CXCL1, and MicroRNA miR-146a Responses to Probiotic Escherichia coli Nissle 1917 and Enteropathogenic E. coli in Human Intestinal Epithelial T84 and Monocytic THP-1 Cells after Apical or Basolateral Infection.
    Sabharwal H; Cichon C; Ölschläger TA; Sonnenborn U; Schmidt MA
    Infect Immun; 2016 Sep; 84(9):2482-92. PubMed ID: 27297392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.